By Professor Ric Day

Journal articles

Mant A; Wodak A; Day R, 1987, 'Benzodiazepine dependence. Strategies for prevention and withdrawal', Current Therapeutics, 28, pp. 59 - 79

Reilly DK; Ray JE; Day RO; Wodak A; Bsocstud DOC; Thompson J, 1987, 'Classification of overdose/self-poisoning presentations to an accident and emergency department', Substance Use and Misuse, 22, pp. 941 - 955, http://dx.doi.org/10.3109/10826088709109691

Day RO; Graham GG; Williams KM; David Champion G; de Jager J, 1987, 'Clinical pharmacology of non-steroidal anti-inflammatory drugs', Pharmacology and Therapeutics, 33, pp. 383 - 433, http://dx.doi.org/10.1016/0163-7258(87)90072-6

Day R; Lam S; Paull P; Wade D, 1987, 'Effect of food and various antacids on the absorption of tenoxicam.', British Journal of Clinical Pharmacology, 24, pp. 323 - 328, http://dx.doi.org/10.1111/j.1365-2125.1987.tb03176.x

Day R; Brooks P, 1987, 'Variations in response to non‐steroidal anti‐inflammatory drugs.', British Journal of Clinical Pharmacology, 23, pp. 655 - 658, http://dx.doi.org/10.1111/j.1365-2125.1987.tb03098.x

Sambrook PN; Champion GD; Browne CD; Cohen ML; Compton P; Day RO; Jager JD, 1986, 'Comparison of methotrexate with azathioprine or 6-mercaptopurine in refractory rheumatoid arthritis: A life-table analysis', Rheumatology, 25, pp. 372 - 375, http://dx.doi.org/10.1093/rheumatology/25.4.372

Goadsby PJ; Day RO; Kwan YL; Miners J; Birkett DJ, 1986, '6-MERCAPTOPURINE-RELATED LEUCOPENIA AND IN VIVO XANTHINE OXIDASE ACTIVITY', The Lancet, 328, pp. 869 - 870, http://dx.doi.org/10.1016/S0140-6736(86)92911-9

Williams K; Day R; Knihinicki R; Duffield A, 1986, 'The stereoselective uptake of ibuprofen enantiomers into adipose tissue', Biochemical Pharmacology, 35, pp. 3403 - 3405, http://dx.doi.org/10.1016/0006-2952(86)90443-0

SAMBROOK PN; CHAMPION GD; COMPTON PJ; BROWNE CD; COHEN M; DAY RO; DEJAGER JP, 1986, 'THERAPEUTIC OUTCOME WITH METHOTREXATE AND AZATHIOPRINE IN RHEUMATOID-ARTHRITIS - A LIFE TABLE ANALYSIS', AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 16, pp. 144 - 144, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1986A500500119&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ray JE; Reilly DK; Day RO, 1986, 'Drugs involved in self-poisoning: Verification by toxicological analysis', Medical Journal of Australia, 144, pp. 455 - 457, http://dx.doi.org/10.5694/j.1326-5377.1986.tb101047.x

Davis A; Day RO; Begg EJ, 1986, 'INTERACTIONS BETWEEN NON‐STEROIDAL ANTI‐INFLAMMATORY DRUGS AND ANTIHYPERTENSIVES AND DIURETICS', Australian and New Zealand Journal of Medicine, 16, pp. 537 - 546, http://dx.doi.org/10.1111/j.1445-5994.1986.tb02031.x

WILLIAMS KM; DAY RO; KNIHINICKI RD; DUFFIELD AM, 1986, 'STEREOSELECTIVE INCORPORATION OF IBUPROFEN ENANTIOMERS INTO ADIPOSE-TISSUE IN RATS AND MAN', ACTA PHARMACOLOGICA ET TOXICOLOGICA, 59, pp. 192 - 192, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1986D896000552&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

DAY RO; WILLIAMS KM; LEE EJ; KNIHINICKI R, 1985, 'DISPOSITION OF ENANTIOMERS OF IBUPROFEN IN PLASMA AND SYNOVIAL-FLUID IN ARTHRITIC DISEASE', CLINICAL AND INVESTIGATIVE MEDICINE-MEDECINE CLINIQUE ET EXPERIMENTALE, 8, pp. A58 - A58, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1985AQS8500134&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Lee E; Williams K; Day R; Graham G; Champion D, 1985, 'Stereoselective disposition of ibuprofen enantiomers in man.', British Journal of Clinical Pharmacology, 19, pp. 669 - 674, http://dx.doi.org/10.1111/j.1365-2125.1985.tb02694.x

Williams KM; Day RO, 1985, 'Stereoselective disposition--basis for variability in response to NSAID's.', Agents and actions. Supplements, 17, pp. 119 - 126, http://dx.doi.org/10.1007/978-3-0348-7720-6_14

Day RO, 1985, 'Variability in response to NSAID.', Agents and actions. Supplements, 17, pp. 15 - 19, http://dx.doi.org/10.1007/978-3-0348-7720-6_1

Ray JD; Day RO, 1984, 'High-performance liquid chromatographic determination of a new anti-inflammatory agent, nabumetone, and its major metabolite in plasma using fluorimetric detection', Journal of Chromatography B: Biomedical Sciences and Applications, 336, pp. 234 - 239, http://dx.doi.org/10.1016/S0378-4347(00)85146-4

Graham GG; Day RO; Champion GD; Lee E; Newton K, 1984, 'Aspects of the clinical pharmacology of non-steroidal anti- inflammatory drugs', Clinics in Rheumatic Diseases, 10, pp. 229 - 249

Day RO; Graham GG; Champion GD; Lee E, 1984, 'Anti-rheumatic drug interactions', Clinics in Rheumatic Diseases, 10, pp. 251 - 275

McGirr EE; Browne CD; Champion GD; Day RO; Sambrook PN, 1984, 'Aurothioglucose in rheumatoid arthritis. Outcome of treatment in patients intolerant of sodium aurothiomalate', Medical Journal of Australia, 141, pp. 349 - 351, http://dx.doi.org/10.5694/j.1326-5377.1984.tb132803.x

Lee EJD; Williams KM; Graham GG; Day RO; Champion GD, 1984, 'Liquid chromatographic determination and plasma concentration profile of optical isomers of ibuprofen in humans', Journal of Pharmaceutical Sciences, 73, pp. 1542 - 1544, http://dx.doi.org/10.1002/jps.2600731112

DAY RO; HARRIS G; BROWN M; GRAHAM G, 1983, 'ASPIRIN GLUCOCORTICOSTEROID INTERACTION IN MAN', CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 10, pp. 717 - 717, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1983RW31100128&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ray JE; Day RO, 1983, 'High‐performance liquid chromatographic analysis of diflunisal in plasma and urine: Application to pharmacokinetic studies in two normal volunteers', Journal of Pharmaceutical Sciences, 72, pp. 1403 - 1405, http://dx.doi.org/10.1002/jps.2600721209

Day RO; Shen DD; Azarnoff DL, 1983, 'Induction of Salicyluric Acid Formation in Rheumatoid Arthritis Patients Treated with Salicylates', Clinical Pharmacokinetics, 8, pp. 263 - 271, http://dx.doi.org/10.2165/00003088-198308030-00005

BEGG EJ; CHINWAH PM; WEBB C; DAY RO; WADE DN, 1983, 'INTERACTION OF MEXILETINE WITH PHENYTOIN', CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 10, pp. 191 - 192, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1983QN17900029&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

RAY JE; REILLY DK; HAAVISTO T; PAULL PD; DAY RO, 1983, 'SURVEY OF DRUG-ABUSE PATTERNS IN A CASUALTY DEPARTMENT POPULATION', CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 10, pp. 715 - 716, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1983RW31100125&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Sambrook PN; Browne CD; Champion GD; Day RO; Vallance JB; Warwick N, 1982, 'Terminations of treatment with gold sodium thiomalate in rheumatoid arthritis', Journal of Rheumatology, 9, pp. 932 - 934

Day RO; Sambrook P; Champion GD; Graham GG, 1982, 'Antimalarials in rheumatic diseases', Australian and New Zealand Journal of Medicine, 12, pp. 645 - 649, http://dx.doi.org/10.1111/j.1445-5994.1982.tb02658.x

Champion GD; Bieri D; Browne CD, 1982, 'Auranofin in rheumatoid arthritis', Journal of Rheumatology, 9, pp. 137 - 145

DAY RO; FURST DE; DROMGOOLE SH; PAULUS HE, 1982, 'DECLINE OF STEADY-STATE SERUM SALICYLIC-ACID CONCENTRATIONS WITH TIME IN NORMAL VOLUNTEERS GIVEN HIGH-DOSE ASPIRIN', AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 12, pp. 557 - 558, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1982PN87700049&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

RAY JE; DAY RO, 1982, 'DIFLUNISAL, A SPECIFIC ANALYTICAL PROCEDURE AND PRELIMINARY PHARMACOKINETICS IN MAN', AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 12, pp. 572 - 572, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1982PN87700093&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Ray JE; Day RO, 1982, 'Diflunisal, a specific analytical procedure and preliminary pharmacokinetics in man', Clinical and Experimental Pharmacology and Physiology, 9, pp. 453

Begg E; Chinwah P; Webb C; Day R; Wade D, 1982, 'Enhanced metabolism of mexiletine after phenytoin administration.', British Journal of Clinical Pharmacology, 14, pp. 219 - 223, http://dx.doi.org/10.1111/j.1365-2125.1982.tb01965.x

Day RO; Furst DE; Dromgoole SH; Kamm B; Roe R; Paulus HE, 1982, 'Relationship of serum naproxen concentration to efficacy in rheumatoid arthritis', Clinical Pharmacology and Therapeutics, 31, pp. 733 - 740, http://dx.doi.org/10.1038/clpt.1982.103

HARRIS G; CAIRNS D; BIERI D; CHAMPION D; DAY R; GRAHAM G, 1982, 'RESPONSE OF RHEUMATOID-ARTHRITIS TO SLOWLY ACTING ANTI-RHEUMATIC DRUGS', AUSTRALIAN AND NEW ZEALAND JOURNAL OF MEDICINE, 12, pp. 561 - 561, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:A1982PN87700060&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Day RO; Pearson CM, 1981, 'Primary inflammatory muscle diseases', Comprehensive Therapy, 7, pp. 22 - 30

Day RO; Furst DE; Dromgoole SH, 1981, 'Decline in steady-state serum levels of salicylate in normal subjects: Preliminary results', Clinical and Experimental Pharmacology and Physiology, 8

Day RO, 1981, 'Effects of exercise performance on drugs used musculoskeletal disorders', Medicine and Science in Sports and Exercise, 13, pp. 272 - 275, http://dx.doi.org/10.1249/00005768-198104000-00013

Day RO; Dromgoole SH; Furst DE; Hignite C; Paulus HE, 1981, 'Formation of methyl ester of salicyluric acid during quantitation of salicyluric acid in urine by high‐pressure liquid chromatography', Journal of Pharmaceutical Sciences, 70, pp. 1090 - 1092, http://dx.doi.org/10.1002/jps.2600700934

Day RO; Furst DE; Dromgoole SH, 1981, 'Naproxen serum level response relationship in rheumatoid arthritis', Australian and New Zealand Journal of Medicine, 11, pp. 720

Furst DE; Day RO; Dromgoole SH, 1981, 'Steady-state serum level vs response relationship for naproxen in rheumatoid arthritis', Clinical Pharmacology and Therapeutics, 29, pp. 247

Day RO; Lindsley HB, 1979, 'Rational use of aspirin and nonsteroidal anti-inflammatory drugs in inflammatory arthritis.', The Journal of the Kansas Medical Society, 80, pp. 155 - 159

Champion GD; Day RO; Paull PD, 1979, 'Clinical pharmacology and efficacy of benorylate in patients with rheumatoid arthritis', Current Therapeutics, 20, pp. 145

Day RO, 1979, 'DEAFNESS DUE TO ASPIRIN', The Journal of Clinical Pharmacology, 19, pp. 328 - 328, http://dx.doi.org/10.1002/j.1552-4604.1979.tb02488.x

Day R; Shen D; Azarnoff D, 1979, 'Decline of steady-state serum salicylate in rheumatoid arthritics given high-dosage salicylate therapy', Clinical Pharmacology and Therapeutics, 25, pp. 220 - 221

Day RO; Shen DD; Azarnoff DL, 1979, 'Effect of high-dosage salicylate therapy on average steady-state serum salicylate and formation of salicylurate in patients with rheumatoid arthritis', Clinical Research, 27

RAY JE; WADE DN; GRAHAM GG; DAY RO, 1979, 'Pharmacokinetics of Carprofen in Plasma and Synovial Fluid', The Journal of Clinical Pharmacology, 19, pp. 635 - 643, http://dx.doi.org/10.1002/j.1552-4604.1979.tb01626.x

Graham G; Champion GD; Day RO, 1979, 'The pharmacokinetics of salicyclate in patients with rheumatoid arthritis', Clinical and Experimental Pharmacology and Physiology, 6, pp. 194

Day RO; Wade DN, 1978, 'Influence of flufenamic acid and calcium ion concentration on the histamine release from rat mast cells induced by compound 48/80 and the calcium ionophore A23187', Biochemical Pharmacology, 27, pp. 1385 - 1387, http://dx.doi.org/10.1016/0006-2952(78)90126-0

Champion GD; Day RO; Paull PD; Graham GG; Owen MS; Haski AL; Hills L, 1978, 'Clinical Pharmacology and Efficacy of Benorylate in Patients with Rheumatoid Arthritis', Australian and New Zealand Journal of Medicine, 8, pp. 22 - 28, http://dx.doi.org/10.1111/j.1445-5994.1978.tb02398.x

Back to profile page